Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2017

Apr 24, 2017

5262_dirs_2017-04-24_8af6bab4-105d-4b46-9023-e117860500b6.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1726D

GlaxoSmithKline PLC

24 April 2017

The following amendment has been made to the Director/PDMR Shareholding announcement released on 19 April 2017 at 13:27 (BST) under RNS No 7391C.

Removal of the text which incorrectly reported that 13.866 Ordinary Shares had been acquired following the re-investment of dividends paid to shareholders on 13 April 2017 on released shares from the Company's 2009 Deferred Annual Bonus Plan on a post-tax basis - Matching Award.

All other details remain unchanged.

The full amended text is shown below.

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Ms C Thomas

b)

Position/status

SVP, HR

c)

Initial notification/

amendment

Amendment

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

b)

Nature of the transaction

Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 13 April 2017 on released shares from the Company's 2009 Deferred Annual Bonus Plan on a post-tax basis - Co-investment shares.

c)

Price(s) and

volume(s)

Price(s) Volume(s)
£16.4042 41.365 (Co-investment shares)

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

e)

Date of the transaction

2017-04-18

f)

Place of the transaction

London Stock Exchange (XLON)

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHKMGZDKDMGNZM